DIN 02217422 — MEPRON 750 MG
MEPRON is a suspension of Atovaquone marketed by GLAXOSMITHKLINE INC. The full Atovaquone monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02217422
- Brand name
- MEPRON
- Active ingredient
- Atovaquone
- Strength
- 750 MG
- Dosage form
- SUSPENSION
- Route
- ORAL
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Antiprotozoal agent (hydroxynaphthoquinone)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Atovaquone products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02556618 | AURO-ATOVAQUONE | 750 MG | SUSPENSION | AURO PHARMA INC | MARKETED |
| 02528495 | GLN-ATOVAQUONE | 750 MG | SUSPENSION | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |